Company Filing History:
1 out of 340 
1 out of 28 
Years Active: 2020
Title: Leanne Cooper: Innovator in Medical Research
Introduction
Leanne Cooper is a prominent inventor based in Alderley, Australia. She has made significant contributions to the field of medical research, particularly in the treatment of diseases related to the EphA4 receptor. Her innovative work has led to the development of valuable therapeutic agents.
Latest Patents
Leanne Cooper holds a patent for "Mammalian EphA4 polypeptide derivatives lacking one or more N-glycosylation sites and method of use thereof." This patent addresses the treatment of diseases exacerbated by signaling via the erythropoietin-producing-hepatoma receptor kinases EphA4. The agents developed through her research are aimed at improving treatment outcomes for affected patients.
Career Highlights
Throughout her career, Leanne has worked with esteemed institutions such as The University of Queensland and the Queensland Institute of Medical Research. Her dedication to advancing medical science has positioned her as a key figure in her field.
Collaborations
Leanne has collaborated with notable colleagues, including Perry Francis Bartlett and Andrew W Boyd. These partnerships have further enhanced her research and contributed to the success of her projects.
Conclusion
Leanne Cooper's innovative work in medical research and her patent contributions highlight her role as a leading inventor in her field. Her efforts continue to pave the way for advancements in the treatment of critical health conditions.